2 results
Approved WMORecruiting
Zie pagina 39-40 van het protocol MO22923 versie 2, 26 Mei 2011
Approved WMOWill not start
The primary objective of this study is to evaluate the efficacy (clinical and MRI) of switching tonatalizumab compared to receiving interferon β1-a or glatiramer acetate.